Journal article

When B cells break bad: development of pathogenic B cells in Sjögren's syndrome.

Joanne H Reed, Gwenny Matthea Verstappen, Maureen Rischmueller, Vanessa L Bryant

Clinical and Experimental Rheumatology | Published : 2020


Primary Sjögren's syndrome (pSS) is often considered a B cell-mediated disease, yet the precise role of B cells in the pathogenesis is not fully understood. This is exemplified by the failure of multiple clinical trials directed at B cell depletion or inhibition. To date, most prognostic markers for severe disease outcomes are autoantibodies, but the underlying mechanisms by which B cells drive diverse disease presentations in pSS likely extend beyond autoantibody production. Here we outline an expanded role of B cells in disease pathogenesis drawing on examples from animal models of SS, and from other autoimmune diseases that share similar clinical or immunological abnormalities. We focus o..

View full abstract

University of Melbourne Researchers